|
|
|
Volumn 24, Issue 3 Suppl 2, 2010, Pages 7-13
|
|
Tailoring initial treatment for newly diagnosed, transplantation-eligible multiple myeloma.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
AGED;
ARTICLE;
CLINICAL TRIAL;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMAN;
MULTIMODALITY CANCER THERAPY;
MULTIPLE MYELOMA;
PERSONALIZED MEDICINE;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CLINICAL TRIALS AS TOPIC;
COMBINED MODALITY THERAPY;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMANS;
INDIVIDUALIZED MEDICINE;
MULTIPLE MYELOMA;
|
|
EID: 77953928043
PISSN: 08909091
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (4)
|
|
References (0)
|
